Arbutus Biopharma Corp Stock Price on December 5, 2024
| ABUS Stock | USD 3.76 0.08 2.17% |
Below is the normalized historical share price chart for Arbutus Biopharma Corp extending back to November 15, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arbutus Biopharma stands at 3.76, as last reported on the 11th of December 2024, with the highest price reaching 3.76 and the lowest price hitting 3.68 during the day.
If you're considering investing in Arbutus Stock, it is important to understand the factors that can impact its price. Arbutus Biopharma Corp secures Sharpe Ratio (or Efficiency) of -0.0767, which signifies that the company had a -0.0767% return per unit of standard deviation over the last 3 months. Arbutus Biopharma Corp exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Arbutus Biopharma's risk adjusted performance of (0.06), and Mean Deviation of 1.76 to double-check the risk estimate we provide.
At this time, Arbutus Biopharma's Common Stock Total Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 174.3 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 124.4 M in 2024. . Price Earnings To Growth Ratio is likely to gain to 1.38 in 2024, whereas Price To Sales Ratio is likely to drop 13.01 in 2024. Arbutus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of August 2015 | 200 Day MA 3.4143 | 50 Day MA 3.7822 | Beta 1.916 |
Arbutus |
Sharpe Ratio = -0.0767
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ABUS |
Estimated Market Risk
| 2.41 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Arbutus Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arbutus Biopharma by adding Arbutus Biopharma to a well-diversified portfolio.
Price Book 6.5238 | Enterprise Value Ebitda (5.64) | Price Sales 103.4308 | Shares Float 136.2 M | Wall Street Target Price 5.136 |
Related Headline
ADMA Biologics Headline on 5th of December 2024
Looking Into ADMA Biologicss Recent Short Interest - Benzing... by news.google.com
Looking Into ADMA Biologicss Recent Short Interest Benzinga
Arbutus Biopharma Valuation on December 5, 2024
It is possible to determine the worth of Arbutus Biopharma on a given historical date. On December 5, 2024 Arbutus was worth 3.79 at the beginning of the trading date compared to the closed value of 3.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arbutus Biopharma stock. Still, in general, we apply an absolute valuation method to find Arbutus Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arbutus Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arbutus Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 3.41 | 3.75 | 3.36 | 3.74 | 1,304,137 | |
12/05/2024 | 3.79 | 3.79 | 3.61 | 3.63 | 788,331 |
| 3.59 | 3.73 | 3.59 | 3.68 | 483,364 |
| Backtest Arbutus Biopharma | | | Arbutus Biopharma History | | | Arbutus Biopharma Valuation | Previous | Next |
Arbutus Biopharma Trading Date Momentum on December 5, 2024
| On December 06 2024 Arbutus Biopharma Corp was traded for 3.68 at the closing time. The top price for the day was 3.73 and the lowest listed price was 3.59 . The trading volume for the day was 483.4 K. The trading history from December 6, 2024 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 1.38% . The overall trading delta against the current closing price is 1.38% . |
Arbutus Biopharma Corp Fundamentals Correlations and Trends
By evaluating Arbutus Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arbutus Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arbutus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Arbutus Biopharma Stock history
Arbutus Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arbutus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arbutus Biopharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arbutus Biopharma stock prices may prove useful in developing a viable investing in Arbutus Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 166 M | 174.3 M | |
| Net Loss | -62.5 M | -65.6 M |
Arbutus Biopharma Quarterly Net Working Capital |
|
Arbutus Biopharma Stock Technical Analysis
Arbutus Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Arbutus Biopharma Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Arbutus Biopharma Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Arbutus Biopharma December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Arbutus Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arbutus Biopharma shares will generate the highest return on investment. By undertsting and applying Arbutus Biopharma stock market strength indicators, traders can identify Arbutus Biopharma Corp entry and exit signals to maximize returns
Arbutus Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arbutus Biopharma's price direction in advance. Along with the technical and fundamental analysis of Arbutus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arbutus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | (0.46) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Arbutus Stock Analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.